GI便検査市場：製品、検査、用途、最終用途別-世界予測2025-2030年

GI便検査市場は、2023年に6億5,169万米ドルと評価され、2024年には6億9,183万米ドルに達すると予測され、CAGR 6.67%で成長し、2030年には10億2,426万米ドルに達すると予測されています。

GI（消化管）便検査は、感染症、炎症性疾患、がんスクリーニングを含む消化管疾患の診断と管理に不可欠な要素です。GI便検査の対象範囲には、便サンプル中の病原体、血液、その他の異常を検出するように設計されたさまざまな検査が含まれ、非侵襲的な診断オプションを提供しています。この検査は疾患の早期発見と管理に不可欠であり、患者の予後改善と最適な治療戦略に貢献します。アプリケーション的には、GI便検査は病院、診断研究所、家庭での検査シナリオなどの臨床現場で広く使用されています。エンドユーザーは主にヘルスケアプロバイダー、患者、研究機関などです。市場の洞察によると、GI疾患の有病率の増加、早期スクリーニングに対する意識の高まり、利便性とプライバシーを考慮した在宅検査キットの採用などにより、堅調な成長軌道が見込まれています。分子診断やマルチターゲット便DNA検査など、検査手法の技術的進歩は、迅速かつ正確な診断の新たな可能性を提示し、主要な成長要因となっています。個別化医療と遠隔医療の進化は、遠隔分析と患者関与の強化を可能にし、この市場の機会をさらに強化します。前向きな見通しとは裏腹に、高度な検査費用の高騰、低資源地域でのアクセス制限、規制上のハードルといった課題が大きな障害となっています。市場関係者は、これらの障壁を克服するために、特に費用対効果が高く、迅速で使いやすい検査ソリューションの技術革新に注力するとともに、認知度向上プログラムを世界的に拡大する必要があります。AIと機械学習による検査の感度と特異度の向上に関する研究開発は、有利な探索領域を提示します。デジタルヘルス統合や予防ヘルスケア戦略などの動向を認識することで、市場競争において優位に立つことができます。機会と課題が混在する市場のダイナミックな性質を理解することは、利害関係者が新たな成長軌道と技術シフトに目標を合わせる上で極めて重要です。

市場力学：急速に進化するGI便検査市場の主要市場インサイトを公開

GI便検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の胃腸障害・疾患の増加
  • 胃腸の健康に対する意識を高めるための政府や財団による取り組み
• 市場抑制要因
  • GI便検査における製品回収に関連する問題
• 市場機会
  • GI便検査法の技術的進歩による、より正確で侵襲性の低いツールの開発
  • ヘルスケア政策の改革と支援策
• 市場の課題
  • 製品の標準化と互換性に関する課題

ポーターのファイブフォース：GI便検査市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：GI便検査市場における外部からの影響の把握

外部マクロ環境要因は、GI便検査市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析GI便検査市場における競合情勢の把握

GI便検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスGI便検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、GI便検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨GI便検査市場における成功への道筋を描く

GI便検査市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で胃腸障害や疾患の発生率が上昇
    • 政府や財団による胃腸の健康に関する意識向上の取り組み
  • 抑制要因
    • GI便検査の製品リコールに関連する問題
  • 機会
    • より正確で侵襲性の低いツールを開発するためのGI便検査方法の技術的進歩
    • ヘルスケア政策の改革と支援策
  • 課題
    • 製品の標準化と互換性に関する課題
• 市場セグメンテーション分析
  • 製品：診断のスピードと精度から消化管便分析装置が好まれる
  • エンドユーザー：診断センターにおけるGI便検査の適用拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 GI便検査市場：製品別

• アナライザー
• 消耗品

第7章 GI便検査市場テスト別

• 細菌検査
• 糞便バイオマーカー検査
  • トランスフェリンアッセイ
  • 腫瘍M2-PK便検査
• 潜血検査
  • グアイアックFOB便検査
  • 免疫FOB凝集試験
  • 免疫FOB ELISA検査
  • ラテラルフロー免疫FOB検査
• 卵子と寄生虫検査

第8章 GI便検査市場：用途別

• がん
• 胃食道逆流症
• 感染
• 炎症性腸疾患

第9章 GI便検査市場：最終用途別

• 診断センター
• ホームケア設定
• 病院・クリニック

第10章 南北アメリカのGI便検査市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のGI便検査市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのGI便検査市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • 非侵襲的大腸がん検査の画期的進歩、ColoSenseがFDAに承認
  • 消化器疾患の早期発見のための消費者に優しい在宅スクリーニングツール、ColoTestの評価
  • ジェネオスコピーとラボコープの提携により革新的な大腸がん検査へのアクセスが向上
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Bio-Rad Laboratories, Inc.
• bioMerieux SA
• Cardinal Health
• Cenogenics Corporation
• CTK Biotech, Inc.
• Danaher Corporation
• Diagnostic Solutions Laboratory, LLC
• DiaSorin S.p.A.
• Eiken Chemical Co., Ltd.
• Emes Software, LLC
• Epitope Diagnostics Inc.
• Geisinger Medical Laboratories
• Genova Diagnostics Inc.
• Helena Laboratories Corporation
• Hologic Inc.
• Lauriston Laboratories Ltd
• Meridian Bioscience Inc.
• Pinnacle BioLabs
• Polymedco, LLC
• Quest Diagnostics
• QuidelOrtho Corporation
• ScheBo Biotech AG
• Siemens Healthineers

LIST OF FIGURES

• FIGURE 1. GI STOOL TESTING MARKET RESEARCH PROCESS
• FIGURE 2. GI STOOL TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL GI STOOL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL GI STOOL TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL GI STOOL TESTING MARKET SIZE, BY TEST, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL GI STOOL TESTING MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL GI STOOL TESTING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL GI STOOL TESTING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES GI STOOL TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES GI STOOL TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. GI STOOL TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. GI STOOL TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. GI STOOL TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL GI STOOL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL GI STOOL TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. GI STOOL TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL GI STOOL TESTING MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL GI STOOL TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL GI STOOL TESTING MARKET SIZE, BY BACTERIA TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL GI STOOL TESTING MARKET SIZE, BY TRANSFERRIN ASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL GI STOOL TESTING MARKET SIZE, BY TUMOR M2-PK STOOL TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL GI STOOL TESTING MARKET SIZE, BY GUAIAC FOB STOOL TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNO FOB AGGLUTINATION TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNO FOB ELISA TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL GI STOOL TESTING MARKET SIZE, BY LATERAL FLOW IMMUNO FOB TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL GI STOOL TESTING MARKET SIZE, BY OVA AND PARASITES TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL GI STOOL TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL GI STOOL TESTING MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL GI STOOL TESTING MARKET SIZE, BY INFECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL GI STOOL TESTING MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL GI STOOL TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL GI STOOL TESTING MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL GI STOOL TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 51. CANADA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. CANADA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 53. CANADA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 54. CANADA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 55. CANADA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. CANADA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES GI STOOL TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 80. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 81. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 83. CHINA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. CHINA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 85. CHINA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 86. CHINA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 87. CHINA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. CHINA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 89. INDIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. INDIA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 91. INDIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 92. INDIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 93. INDIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. INDIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 95. INDONESIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. INDONESIA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 97. INDONESIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 98. INDONESIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 99. INDONESIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. INDONESIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 101. JAPAN GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. JAPAN GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 103. JAPAN GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 104. JAPAN GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 105. JAPAN GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. JAPAN GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 107. MALAYSIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. MALAYSIA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 109. MALAYSIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 110. MALAYSIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 111. MALAYSIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. MALAYSIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 113. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 115. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 116. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 117. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 119. SINGAPORE GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. SINGAPORE GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 121. SINGAPORE GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 122. SINGAPORE GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 123. SINGAPORE GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. SINGAPORE GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 131. TAIWAN GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. TAIWAN GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 133. TAIWAN GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 134. TAIWAN GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 135. TAIWAN GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. TAIWAN GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 137. THAILAND GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. THAILAND GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 139. THAILAND GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 140. THAILAND GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 141. THAILAND GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. THAILAND GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 143. VIETNAM GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. VIETNAM GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 145. VIETNAM GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 146. VIETNAM GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 147. VIETNAM GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. VIETNAM GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 156. DENMARK GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 157. DENMARK GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 158. DENMARK GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 159. DENMARK GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 160. DENMARK GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. DENMARK GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 162. EGYPT GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 163. EGYPT GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 164. EGYPT GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 165. EGYPT GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 166. EGYPT GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. EGYPT GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 168. FINLAND GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 169. FINLAND GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 170. FINLAND GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 171. FINLAND GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 172. FINLAND GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. FINLAND GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 174. FRANCE GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 175. FRANCE GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 176. FRANCE GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 177. FRANCE GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 178. FRANCE GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. FRANCE GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 180. GERMANY GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 181. GERMANY GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 182. GERMANY GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 183. GERMANY GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 184. GERMANY GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. GERMANY GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 186. ISRAEL GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 187. ISRAEL GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 188. ISRAEL GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 189. ISRAEL GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 190. ISRAEL GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. ISRAEL GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 192. ITALY GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 193. ITALY GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 194. ITALY GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 195. ITALY GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 196. ITALY GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 197. ITALY GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 198. NETHERLANDS GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 199. NETHERLANDS GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 200. NETHERLANDS GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 201. NETHERLANDS GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 202. NETHERLANDS GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 203. NETHERLANDS GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 204. NIGERIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 205. NIGERIA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 206. NIGERIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 207. NIGERIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 208. NIGERIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 209. NIGERIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 210. NORWAY GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 211. NORWAY GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 212. NORWAY GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 213. NORWAY GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 214. NORWAY GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 215. NORWAY GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 216. POLAND GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 217. POLAND GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 218. POLAND GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 219. POLAND GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 220. POLAND GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 221. POLAND GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 222. QATAR GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 223. QATAR GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 224. QATAR GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 225. QATAR GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 226. QATAR GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 227. QATAR GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 228. RUSSIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 229. RUSSIA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 230. RUSSIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 231. RUSSIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 232. RUSSIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 233. RUSSIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 234. SAUDI ARABIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 236. SAUDI ARABIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 238. SAUDI ARABIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH AFRICA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH AFRICA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 244. SOUTH AFRICA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 246. SPAIN GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 247. SPAIN GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 248. SPAIN GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 249. SPAIN GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 250. SPAIN GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 251. SPAIN GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 252. SWEDEN GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 253. SWEDEN GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 254. SWEDEN GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 255. SWEDEN GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 256. SWEDEN GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 257. SWEDEN GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 258. SWITZERLAND GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 259. SWITZERLAND GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 260. SWITZERLAND GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 261. SWITZERLAND GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 262. SWITZERLAND GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 263. SWITZERLAND GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 264. TURKEY GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 265. TURKEY GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 266. TURKEY GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 267. TURKEY GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 268. TURKEY GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 269. TURKEY GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 270. UNITED ARAB EMIRATES GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 276. UNITED KINGDOM GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 278. UNITED KINGDOM GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
• TABLE 280. UNITED KINGDOM GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 282. GI STOOL TESTING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 283. GI STOOL TESTING MARKET, FPNV POSITIONING MATRIX, 2023

The GI Stool Testing Market was valued at USD 651.69 million in 2023, expected to reach USD 691.83 million in 2024, and is projected to grow at a CAGR of 6.67%, to USD 1,024.26 million by 2030.

GI (Gastrointestinal) stool testing is an essential component in diagnosing and managing gastrointestinal disorders, including infections, inflammatory diseases, and cancer screening. The scope of GI stool testing encompasses a range of tests designed to detect pathogens, blood, and other anomalies in stool samples, offering a non-invasive diagnostic option. This testing is crucial for early detection and management of diseases, contributing to better patient outcomes and optimal treatment strategies. Application-wise, GI stool testing has widespread use in clinical settings such as hospitals, diagnostics laboratories, and home-testing scenarios. End-users primarily include healthcare providers, patients, and research institutions. Market insights reveal a robust growth trajectory, driven by increasing prevalence of GI diseases, rising awareness about early screening, and the adoption of home-testing kits due to convenience and privacy. Technological advancements in testing methodologies, such as molecular diagnostics and multi-target stool DNA testing, are key growth influencers, presenting novel possibilities for rapid and accurate diagnosis. The evolving landscape of personalized medicine and telehealth further bolsters opportunities in this market, enabling remote analysis and enhanced patient engagement. Despite the positive outlook, challenges such as high costs of advanced testing, limited accessibility in low-resource regions, and regulatory hurdles pose significant roadblocks. Market players need to focus on innovation, especially in cost-effective, rapid, and user-friendly testing solutions, as well as expanding awareness programs worldwide to overcome these barriers. Research and development in enhancing sensitivity and specificity of tests through AI and machine learning present lucrative areas for exploration. Recognizing trends like digital health integration and preventive healthcare strategies can provide competitive market advantages. Understanding the dynamic nature of the market, with its mix of opportunities and challenges, is crucial for stakeholders to align their objectives with emerging growth trajectories and technological shifts.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving GI Stool Testing Market

The GI Stool Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidences of gastrointestinal disorders and diseases across the world
  • Efforts by governments and foundations to raise awareness for gastrointestinal health
• Market Restraints
  • Issues associated with product recalls in GI stool testing
• Market Opportunities
  • Technological advancements in GI stool testing methods to develop more accurate and less invasive tools
  • Reforms and supportive measures in healthcare policies
• Market Challenges
  • Challenges with product standardization and compatibility

Porter's Five Forces: A Strategic Tool for Navigating the GI Stool Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the GI Stool Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the GI Stool Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the GI Stool Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the GI Stool Testing Market

A detailed market share analysis in the GI Stool Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the GI Stool Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the GI Stool Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the GI Stool Testing Market

A strategic analysis of the GI Stool Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the GI Stool Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Bio-Rad Laboratories, Inc., bioMerieux SA, Cardinal Health, Cenogenics Corporation, CTK Biotech, Inc., Danaher Corporation, Diagnostic Solutions Laboratory, LLC, DiaSorin S.p.A., Eiken Chemical Co., Ltd., Emes Software, LLC, Epitope Diagnostics Inc., Geisinger Medical Laboratories, Genova Diagnostics Inc., Helena Laboratories Corporation, Hologic Inc., Lauriston Laboratories Ltd, Meridian Bioscience Inc., Pinnacle BioLabs, Polymedco, LLC, Quest Diagnostics, QuidelOrtho Corporation, ScheBo Biotech AG, and Siemens Healthineers.

Market Segmentation & Coverage

This research report categorizes the GI Stool Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Analyzers and Consumables.
• Based on Test, market is studied across Bacteria Test, Fecal Biomarkers Test, Occult Blood Test, and Ova and Parasites Test. The Fecal Biomarkers Test is further studied across Transferrin Assays and Tumor M2-PK Stool Test. The Occult Blood Test is further studied across Guaiac FOB Stool Test, Immuno FOB Agglutination Test, Immuno FOB ELISA Test, and Lateral Flow Immuno FOB Test.
• Based on Application, market is studied across Cancer, Gastroesophageal Reflux Disease, Infection, and Inflammatory Bowel Disease.
• Based on End-use, market is studied across Diagnostic Centers, Homecare Settings, and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidences of gastrointestinal disorders and diseases across the world
    • 5.1.1.2. Efforts by governments and foundations to raise awareness for gastrointestinal health
  • 5.1.2. Restraints
    • 5.1.2.1. Issues associated with product recalls in GI stool testing
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in GI stool testing methods to develop more accurate and less invasive tools
    • 5.1.3.2. Reforms and supportive measures in healthcare policies
  • 5.1.4. Challenges
    • 5.1.4.1. Challenges with product standardization and compatibility
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Preference towards GI stool analyzers due to their speed and accuracy in diagnostics
  • 5.2.2. End-Users: Expanding application of GI Stool Testing in diagnostic centers
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. GI Stool Testing Market, by Product

• 6.1. Introduction
• 6.2. Analyzers
• 6.3. Consumables

7. GI Stool Testing Market, by Test

• 7.1. Introduction
• 7.2. Bacteria Test
• 7.3. Fecal Biomarkers Test
  • 7.3.1. Transferrin Assays
  • 7.3.2. Tumor M2-PK Stool Test
• 7.4. Occult Blood Test
  • 7.4.1. Guaiac FOB Stool Test
  • 7.4.2. Immuno FOB Agglutination Test
  • 7.4.3. Immuno FOB ELISA Test
  • 7.4.4. Lateral Flow Immuno FOB Test
• 7.5. Ova and Parasites Test

8. GI Stool Testing Market, by Application

• 8.1. Introduction
• 8.2. Cancer
• 8.3. Gastroesophageal Reflux Disease
• 8.4. Infection
• 8.5. Inflammatory Bowel Disease

9. GI Stool Testing Market, by End-use

• 9.1. Introduction
• 9.2. Diagnostic Centers
• 9.3. Homecare Settings
• 9.4. Hospitals & Clinics

10. Americas GI Stool Testing Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific GI Stool Testing Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa GI Stool Testing Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. FDA Approval of ColoSense, A Breakthrough in Noninvasive Colorectal Cancer Screening
  • 13.3.2. Evaluation of ColoTest, A Consumer-Friendly, At-Home Screening Tool for Early Detection of Gastrointestinal Conditions
  • 13.3.3. Geneoscopy and Labcorp Partnership Elevates Access to Innovative Colorectal Cancer Screening
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Bio-Rad Laboratories, Inc.
• 3. bioMerieux SA
• 4. Cardinal Health
• 5. Cenogenics Corporation
• 6. CTK Biotech, Inc.
• 7. Danaher Corporation
• 8. Diagnostic Solutions Laboratory, LLC
• 9. DiaSorin S.p.A.
• 10. Eiken Chemical Co., Ltd.
• 11. Emes Software, LLC
• 12. Epitope Diagnostics Inc.
• 13. Geisinger Medical Laboratories
• 14. Genova Diagnostics Inc.
• 15. Helena Laboratories Corporation
• 16. Hologic Inc.
• 17. Lauriston Laboratories Ltd
• 18. Meridian Bioscience Inc.
• 19. Pinnacle BioLabs
• 20. Polymedco, LLC
• 21. Quest Diagnostics
• 22. QuidelOrtho Corporation
• 23. ScheBo Biotech AG
• 24. Siemens Healthineers